Myostatin: a potential therapeutic target for metabolic syndrome.
Yang M, Liu C, Jiang N, Liu Y, Luo S, Li C, Zhao H, Han Y, Chen W, Li L, Xiao L, Sun L.
Yang M, et al. Among authors: li c, li l.
Front Endocrinol (Lausanne). 2023 May 23;14:1181913. doi: 10.3389/fendo.2023.1181913. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37288303
Free PMC article.
Review.